Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 14 | 2022 | 376 | 2.850 |
Why?
|
Tobacco Use Disorder | 8 | 2020 | 236 | 1.830 |
Why?
|
Mental Disorders | 8 | 2015 | 897 | 1.570 |
Why?
|
Smoke-Free Policy | 2 | 2017 | 13 | 1.050 |
Why?
|
Nicotinic Agonists | 3 | 2020 | 100 | 0.850 |
Why?
|
Smoking | 7 | 2016 | 1392 | 0.790 |
Why?
|
Mental Health | 3 | 2021 | 559 | 0.680 |
Why?
|
Health Promotion | 3 | 2017 | 686 | 0.670 |
Why?
|
Tobacco Use Cessation | 2 | 2017 | 21 | 0.650 |
Why?
|
Bipolar Disorder | 5 | 2009 | 208 | 0.640 |
Why?
|
Substance Abuse Treatment Centers | 2 | 2017 | 42 | 0.630 |
Why?
|
Nicotine | 1 | 2020 | 266 | 0.610 |
Why?
|
Health Policy | 2 | 2020 | 334 | 0.540 |
Why?
|
Behavior, Addictive | 2 | 2020 | 81 | 0.530 |
Why?
|
Prisoners | 1 | 2017 | 124 | 0.490 |
Why?
|
Organizational Policy | 1 | 2015 | 68 | 0.480 |
Why?
|
Hotlines | 3 | 2021 | 29 | 0.450 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 414 | 0.440 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 774 | 0.430 |
Why?
|
Inpatients | 1 | 2017 | 378 | 0.430 |
Why?
|
Tobacco Smoke Pollution | 1 | 2015 | 217 | 0.400 |
Why?
|
Community Networks | 1 | 2011 | 55 | 0.360 |
Why?
|
Mental Health Services | 3 | 2010 | 321 | 0.360 |
Why?
|
Family Therapy | 1 | 2007 | 62 | 0.280 |
Why?
|
Depressive Disorder, Major | 2 | 2022 | 302 | 0.250 |
Why?
|
Substance-Related Disorders | 2 | 2010 | 946 | 0.230 |
Why?
|
Benzazepines | 2 | 2013 | 37 | 0.210 |
Why?
|
Quinoxalines | 2 | 2013 | 60 | 0.210 |
Why?
|
Activities of Daily Living | 1 | 2005 | 351 | 0.200 |
Why?
|
Humans | 23 | 2023 | 115052 | 0.200 |
Why?
|
Adolescent | 13 | 2022 | 17866 | 0.200 |
Why?
|
Patient Satisfaction | 1 | 2005 | 580 | 0.190 |
Why?
|
Disease Management | 1 | 2005 | 564 | 0.190 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 676 | 0.180 |
Why?
|
Motivation | 1 | 2005 | 498 | 0.180 |
Why?
|
Adult | 13 | 2017 | 30658 | 0.180 |
Why?
|
Standard of Care | 1 | 2020 | 63 | 0.170 |
Why?
|
Colorado | 4 | 2013 | 4089 | 0.170 |
Why?
|
Young Adult | 8 | 2016 | 10498 | 0.170 |
Why?
|
Prevalence | 3 | 2015 | 2255 | 0.170 |
Why?
|
Smoking Prevention | 3 | 2016 | 157 | 0.170 |
Why?
|
Female | 15 | 2022 | 59619 | 0.160 |
Why?
|
Psychotic Disorders | 2 | 2012 | 120 | 0.150 |
Why?
|
Counseling | 1 | 2021 | 342 | 0.150 |
Why?
|
Feasibility Studies | 1 | 2021 | 747 | 0.150 |
Why?
|
Male | 13 | 2022 | 55737 | 0.150 |
Why?
|
Anxiety Disorders | 2 | 2013 | 307 | 0.150 |
Why?
|
Arkansas | 1 | 2017 | 13 | 0.150 |
Why?
|
Depressive Disorder | 2 | 2013 | 333 | 0.150 |
Why?
|
Health Status | 2 | 2015 | 722 | 0.140 |
Why?
|
Middle Aged | 11 | 2022 | 26831 | 0.140 |
Why?
|
Aged | 9 | 2016 | 19122 | 0.130 |
Why?
|
Program Development | 2 | 2009 | 346 | 0.130 |
Why?
|
Intention | 1 | 2017 | 143 | 0.130 |
Why?
|
Schizophrenia | 2 | 2012 | 416 | 0.120 |
Why?
|
Statistics as Topic | 2 | 2006 | 298 | 0.120 |
Why?
|
Population | 1 | 2013 | 28 | 0.110 |
Why?
|
California | 1 | 2015 | 364 | 0.110 |
Why?
|
Varenicline | 3 | 2022 | 22 | 0.100 |
Why?
|
Suicide | 2 | 2009 | 502 | 0.100 |
Why?
|
Program Evaluation | 1 | 2017 | 825 | 0.100 |
Why?
|
Cooperative Behavior | 1 | 2015 | 383 | 0.100 |
Why?
|
Attitude | 1 | 2013 | 227 | 0.100 |
Why?
|
Caregivers | 2 | 2009 | 712 | 0.100 |
Why?
|
Health Surveys | 1 | 2013 | 443 | 0.100 |
Why?
|
Healthcare Disparities | 1 | 2016 | 480 | 0.090 |
Why?
|
Poverty | 1 | 2013 | 443 | 0.090 |
Why?
|
United States | 5 | 2016 | 12227 | 0.090 |
Why?
|
Health Services Accessibility | 2 | 2023 | 765 | 0.090 |
Why?
|
Government Agencies | 1 | 2010 | 15 | 0.090 |
Why?
|
Family Health | 2 | 2009 | 194 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 1081 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 245 | 0.080 |
Why?
|
Prisons | 1 | 2010 | 72 | 0.080 |
Why?
|
Depression | 2 | 2022 | 1136 | 0.080 |
Why?
|
Patient Care Planning | 1 | 2009 | 139 | 0.080 |
Why?
|
Expressed Emotion | 1 | 2007 | 17 | 0.070 |
Why?
|
Focus Groups | 1 | 2009 | 385 | 0.070 |
Why?
|
Needs Assessment | 1 | 2009 | 316 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2015 | 4420 | 0.070 |
Why?
|
Public Sector | 1 | 2006 | 18 | 0.070 |
Why?
|
Pilot Projects | 1 | 2011 | 1375 | 0.070 |
Why?
|
Family Relations | 1 | 2007 | 86 | 0.070 |
Why?
|
Interviews as Topic | 1 | 2009 | 584 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2022 | 9123 | 0.070 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2013 | 757 | 0.060 |
Why?
|
Surveys and Questionnaires | 1 | 2017 | 4631 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2016 | 6357 | 0.060 |
Why?
|
Personality Assessment | 1 | 2005 | 79 | 0.060 |
Why?
|
Personality Inventory | 1 | 2005 | 133 | 0.060 |
Why?
|
Suicide, Attempted | 1 | 2007 | 314 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2009 | 682 | 0.060 |
Why?
|
Risk | 1 | 2006 | 815 | 0.060 |
Why?
|
Health Personnel | 1 | 2009 | 574 | 0.050 |
Why?
|
Health Behavior | 1 | 2009 | 704 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2009 | 2389 | 0.050 |
Why?
|
Bupropion | 1 | 2022 | 39 | 0.050 |
Why?
|
Health Services | 1 | 2023 | 103 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 1127 | 0.050 |
Why?
|
Polyesters | 1 | 2022 | 64 | 0.050 |
Why?
|
Comorbidity | 1 | 2006 | 1457 | 0.050 |
Why?
|
Databases, Factual | 1 | 2006 | 1132 | 0.050 |
Why?
|
Psychometrics | 1 | 2005 | 608 | 0.050 |
Why?
|
Peer Group | 1 | 2023 | 203 | 0.050 |
Why?
|
Smokers | 1 | 2022 | 129 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 1399 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2015 | 12548 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 1184 | 0.040 |
Why?
|
Alcoholism | 1 | 2006 | 716 | 0.040 |
Why?
|
Rural Population | 1 | 2022 | 446 | 0.040 |
Why?
|
Cohort Studies | 1 | 2009 | 4904 | 0.040 |
Why?
|
Family | 1 | 2022 | 591 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2013 | 1665 | 0.040 |
Why?
|
Quality of Life | 1 | 2009 | 2360 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2005 | 2799 | 0.040 |
Why?
|
Chronic Disease | 1 | 2023 | 1591 | 0.040 |
Why?
|
Alaska | 1 | 2016 | 78 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2006 | 4411 | 0.030 |
Why?
|
Parents | 1 | 2022 | 1190 | 0.030 |
Why?
|
Prospective Studies | 1 | 2005 | 6232 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2013 | 195 | 0.020 |
Why?
|
Canada | 1 | 2012 | 322 | 0.020 |
Why?
|
Indians, North American | 1 | 2016 | 570 | 0.020 |
Why?
|
Observation | 1 | 2009 | 49 | 0.020 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 242 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2013 | 397 | 0.020 |
Why?
|
Checklist | 1 | 2009 | 84 | 0.020 |
Why?
|
Self Concept | 1 | 2009 | 214 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2009 | 484 | 0.020 |
Why?
|
Anxiety | 1 | 2013 | 845 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 1812 | 0.020 |
Why?
|
Recurrence | 1 | 2007 | 941 | 0.010 |
Why?
|
Child | 1 | 2022 | 18409 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 6142 | 0.010 |
Why?
|